Mode of Transmission Affects the Sensitivity of Human Immunodeficiency Virus Type 1 to Restriction by Rhesus TRIM5α
暂无分享,去创建一个
Joseph Sodroski | Nikolay Korokhov | Guido Silvestri | James L. Riley | J. Sodroski | G. Silvestri | Matthew H. Stremlau | J. Riley | R. Carroll | L. Humeau | Matthew Stremlau | Richard G. Carroll | Laurent M. Humeau | Max W. Richardson | M. Richardson | N. Korokhov
[1] Q. Sattentau,et al. Dangerous liaisons at the virological synapse. , 2004, The Journal of clinical investigation.
[2] R. Akkina,et al. TRIM5alpharh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] S. Nisole,et al. TRIM family proteins: retroviral restriction and antiviral defence , 2005, Nature Reviews Microbiology.
[4] D. Birx,et al. Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection , 2002, Nature Medicine.
[5] M. Yap,et al. All Three Variable Regions of the TRIM5α B30.2 Domain Can Contribute to the Specificity of Retrovirus Restriction , 2006, Journal of Virology.
[6] R. Tsien,et al. A monomeric red fluorescent protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] R Blumenthal,et al. Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.
[8] Jonathan P. Stoye,et al. A Single Amino Acid Change in the SPRY Domain of Human Trim5α Leads to HIV-1 Restriction , 2005, Current Biology.
[9] C. June,et al. CD28 and Inducible Costimulatory Protein Src Homology 2 Binding Domains Show Distinct Regulation of Phosphatidylinositol 3-Kinase, Bcl-xL, and IL-2 Expression in Primary Human CD4 T Lymphocytes 1 , 2003, The Journal of Immunology.
[10] Claire Hivroz,et al. ZAP‐70 kinase regulates HIV cell‐to‐cell spread and virological synapse formation , 2007, The EMBO journal.
[11] Joseph Sodroski,et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Sodroski,et al. Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5α Determines the Potency of Human Immunodeficiency Virus Restriction , 2005, Journal of Virology.
[13] Y. Takeuchi,et al. Restriction of lentivirus in monkeys , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[14] John R. Mascola,et al. Gene transfer in humans using a conditionally replicating lentiviral vector , 2006, Proceedings of the National Academy of Sciences.
[15] E. Freed,et al. Retrovirus budding. , 2004, Virus research.
[16] J. Trowsdale,et al. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function , 2007, Proceedings of the National Academy of Sciences.
[17] W. Mothes,et al. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission , 2007, Nature Cell Biology.
[18] Smaroula Dilioglou,et al. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector , 2004, Nature Biotechnology.
[19] V. Slepushkin,et al. Safe two‐plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one‐step protocol , 2004, The journal of gene medicine.
[20] T. Hope,et al. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Pérez-Caballero,et al. No effect of endogenous TRIM5α on HIV-1 production , 2008, Nature Medicine.
[22] S. Goff. Genetic control of retrovirus susceptibility in mammalian cells. , 2004, Annual review of genetics.
[23] S. O’Brien,et al. Exclusive and Persistent Use of the Entry Coreceptor CXCR4 by Human Immunodeficiency Virus Type 1 from a Subject Homozygous for CCR5 Δ32 , 1998, Journal of Virology.
[24] A. Engelman,et al. Proteasome Inhibition Reveals that a Functional Preintegration Complex Intermediate Can Be Generated during Restriction by Diverse TRIM5 Proteins , 2006, Journal of Virology.
[25] A. Haase,et al. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. , 1999, Annual review of immunology.
[26] R. Akkina,et al. Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM 5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue. , 2008, Human gene therapy.
[27] D. Trono,et al. A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.
[28] S. Anderson,et al. The Mode and Duration of Anti-CD28 Costimulation Determine Resistance to Infection by Macrophage-Tropic Strains of Human Immunodeficiency Virus Type 1 In Vitro , 1999, Journal of Virology.
[29] S. Goff. Retrovirus restriction factors. , 2004, Molecular cell.
[30] C. June,et al. Principles of adoptive T cell cancer therapy. , 2007, The Journal of clinical investigation.
[31] Y. Ikeda,et al. Rhesus monkey TRIM5α restricts HIV-1 production through rapid degradation of viral Gag polyproteins , 2007, Nature Medicine.
[32] H. Fox,et al. Trim5α Accelerates Degradation of Cytosolic Capsid Associated with Productive HIV-1 Entry* , 2006, Journal of Biological Chemistry.
[33] T. Hope,et al. Heat Shock Perturbs TRIM5α Restriction of Human Immunodeficiency Virus Type 1 , 2007, Journal of Virology.
[34] Trushar R. Patel,et al. Blockade of HIV-1 Infection of New World Monkey Cells Occurs Primarily at the Stage of Virus Entry , 2002, The Journal of experimental medicine.
[35] A. Ishimoto,et al. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells , 1991, Journal of virology.
[36] B. Levine,et al. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. , 1997, Science.
[37] O. Schwartz,et al. Inefficient Human Immunodeficiency Virus Replication in Mobile Lymphocytes , 2006, Journal of Virology.
[38] Clare Jolly,et al. HIV-1 Cell to Cell Transfer across an Env-induced, Actin-dependent Synapse , 2004, The Journal of experimental medicine.
[39] C. M. Owens,et al. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.
[40] Joseph Sodroski,et al. Removal of Arginine 332 Allows Human TRIM5α To Bind Human Immunodeficiency Virus Capsids and To Restrict Infection , 2006, Journal of Virology.
[41] S. Zolla-Pazner,et al. Neutralization Profiles of Primary Human Immunodeficiency Virus Type 1 Isolates in the Context of Coreceptor Usage , 1998, Journal of Virology.
[42] A. Fauci,et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. , 1989, Journal of immunology.